UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

Fluid Stewardship of Maintenance Intravenous Fluids

Journal of Pharmacy Practice, 2022-10, Vol.35 (5), p.769-782

2022

Volltextzugriff (PDF)

Belantamab Mafodotin-blmf: A Novel Antibody-Drug Conjugate for Treatment of Patients With Relapsed/Refractory Multiple Myeloma

Journal of the advanced practitioner in oncology, 2022-01, Vol.13 (1), p.77-85

2022

Volltextzugriff (PDF)

Clinical and Cost Comparison Evaluation of Inpatient Versus Outpatient Administration of EPOCH-Containing Regimens in Non-Hodgkin Lymphoma

Journal of pharmacy practice, 2017-08, Vol.30 (4), p.400-405

2017

Volltextzugriff (PDF)

Assessing Outcomes in Patients With Multiple Myeloma Postautologous Stem Cell Transplantation: Contrasting the Effects of Melphalan Dosages at 200 mg/m2 versus 140 mg/m2

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24 (9), p.642-647

2024

Volltextzugriff (PDF)

Incidence and utility of follow-up blood cultures in cancer patients with gram-negative bacteremia

Diagnostic microbiology and infectious disease, 2021-10, Vol.101 (2), p.115444-115444, Article 115444

2021

Volltextzugriff (PDF)

Reply to: Intravenous Magnesium Replacement in Patients With Hypomagnesemia: Time Is of the Essence

Hospital pharmacy (Philadelphia), 2020-04, Vol.55 (2), p.84-84

2020

Volltextzugriff (PDF)

Assessing the impact of adding acetazolamide to oral or intravenous sodium bicarbonate as compared with intravenous bicarbonate monotherapy as urinary alkalinization in adults receiving high-dose methotrexate

Supportive care in cancer, 2021-03, Vol.29 (3), p.1527-1534

2021

Volltextzugriff (PDF)

Mixed outpatient–inpatient autologous stem cell transplant for multiple myeloma: A cost-saving initiative in a resource constrained environment

Journal of oncology pharmacy practice, 2017-07, Vol.23 (5), p.384-388

2017

Volltextzugriff (PDF)

Acute Kidney Injury in Hematopoietic Cell Transplantation Patients Receiving Vancomycin and Piperacillin/Tazobactam Versus Vancomycin and Cefepime

Biology of blood and marrow transplantation, 2018-04, Vol.24 (4), p.820-826

2018

Volltextzugriff (PDF)

Emerging Role of Olanzapine for Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting

Pharmacotherapy, 2016-02, Vol.36 (2), p.218-229

2016

Volltextzugriff (PDF)

Translating Clinical Decision-Making Skills From a Critical Care Pharmacy Elective to the Required Curriculum

American journal of pharmaceutical education, 2024-01, Vol.88 (1), p.100599-100599, Article 100599

2024

Volltextzugriff (PDF)

Clinical Outcomes of Acid Suppressive Therapy Use in Hematology/Oncology Patients at an Academic Medical Center

The Annals of pharmacotherapy, 2016-07, Vol.50 (7), p.541

2016

Volltextzugriff (PDF)

Prolonged versus short infusion rates for intravenous magnesium sulfate administration in hematopoietic cell transplant patients

Supportive care in cancer, 2018-08, Vol.26 (8), p.2809-2814

2018

Volltextzugriff (PDF)

Immune-mediated adverse events following influenza vaccine in cancer patients receiving immune checkpoint inhibitors

Journal of oncology pharmacy practice, 2020-04, Vol.26 (3), p.647-654

2020

Volltextzugriff (PDF)

Evaluating Clostridioides difficile infection (CDI) treatment duration in hematology/oncology patients receiving concurrent non-CDI antibiotics

Journal of oncology pharmacy practice, 2022-04, Vol.28 (3), p.542-550

2022

Volltextzugriff (PDF)

Evaluation of romiplostim for the treatment of secondary failure of platelet recovery among allogeneic hematopoietic stem cell transplant patients

Journal of oncology pharmacy practice, 2017-01, Vol.23 (1), p.10-17

2017

Volltextzugriff (PDF)

Impact of fluoroquinolone prophylaxis on infectious-related outcomes after hematopoietic cell transplantation

Journal of oncology pharmacy practice, 2019-03, Vol.25 (2), p.326-332

2019

Volltextzugriff (PDF)

Obinutuzumab: A Novel Anti-CD20 Monoclonal Antibody for Chronic Lymphocytic Leukemia

Journal of the advanced practitioner in oncology, 2015-07, Vol.6 (4), p.370-374

2015

Volltextzugriff (PDF)

Randomized, Placebo-Controlled, Phase III Trial of Fosaprepitant, Ondansetron, Dexamethasone (FOND) Versus FOND Plus Olanzapine (FOND-O) for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients with Hematologic Malignancies Receiving Highly Emetogenic Chemotherapy and Hematopoietic Cell Transplantation Regimens: The FOND-O Trial

Biology of blood and marrow transplantation, 2018-10, Vol.24 (10), p.2065-2071

2018

Volltextzugriff (PDF)

Bosutinib: a novel src/abl kinase inhibitor for chronic myelogenous leukemia

Journal of the advanced practitioner in oncology, 2013-11, Vol.4 (6), p.451-455

2013

Volltextzugriff (PDF)

Fosaprepitant for the prevention of nausea and vomiting in patients receiving BEAM or high-dose melphalan before autologous hematopoietic stem cell transplant

Journal of oncology pharmacy practice, 2016-06, Vol.22 (3), p.416-422

2016

Volltextzugriff (PDF)

The Hematopoietic Cell Transplant Pharmacist: Roles, Responsibilities, and Recommendations from the ASBMT Pharmacy Special Interest Group

Biology of blood and marrow transplantation, 2018-05, Vol.24 (5), p.914-922

2018

Volltextzugriff (PDF)

Prognostic value of complete remission with superior platelet counts in acute myeloid leukemia

The Journal of community and supportive oncology, 2016-02, Vol.14 (2), p.66-71

2016

Volltextzugriff (PDF)

Outcomes for Patients with Multiple Myeloma after Receipt of Melphalan 200mg/m2 Versus 140 Mg/m2 for Autologous Stem Cell Transplantation

Transplantation and cellular therapy, 2024-02, Vol.30 (2), p.S452-S452

2024

Volltextzugriff (PDF)

Academic Center Outreach to Community Practices Increases Transplant Referrals and Possibly Reduce Racial Disparities

Transplantation and cellular therapy, 2022-03, Vol.28 (3), p.S482-S483

2022

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(19)
Science & Technology
(19)
Humans
(13)
Pharmacology & Pharmacy
(12)
Oncology
(11)
Female
(10)
Male
(9)
Middle Aged
(9)
Retrospective Studies
(9)
Adult
(6)
Aged
(6)
Hematology
(6)
Transplantation
(5)
Adolescent
(3)
Autografts
(3)
Hematopoietic Stem Cell Transplantation
(3)
Hematopoietic Stem Cell Transplantation - Methods
(3)
Immunology
(3)
Incidence
(3)
Nausea
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Fluid Stewardship of Maintenance Intravenous Fluids

Belantamab Mafodotin-blmf: A Novel Antibody-Drug Conjugate for Treatment of Patients With Relapsed/Refractory Multiple Myeloma

Clinical and Cost Comparison Evaluation of Inpatient Versus Outpatient Administration of EPOCH-Containing Regimens in Non-Hodgkin Lymphoma

Assessing Outcomes in Patients With Multiple Myeloma Postautologous Stem Cell Transplantation: Contrasting the Effects of Melphalan Dosages at 200 mg/m2 versus 140 mg/m2

Incidence and utility of follow-up blood cultures in cancer patients with gram-negative bacteremia

Reply to: Intravenous Magnesium Replacement in Patients With Hypomagnesemia: Time Is of the Essence

Assessing the impact of adding acetazolamide to oral or intravenous sodium bicarbonate as compared with intravenous bicarbonate monotherapy as urinary alkalinization in adults receiving high-dose methotrexate

Mixed outpatient–inpatient autologous stem cell transplant for multiple myeloma: A cost-saving initiative in a resource constrained environment

Acute Kidney Injury in Hematopoietic Cell Transplantation Patients Receiving Vancomycin and Piperacillin/Tazobactam Versus Vancomycin and Cefepime

Emerging Role of Olanzapine for Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting

Translating Clinical Decision-Making Skills From a Critical Care Pharmacy Elective to the Required Curriculum

Clinical Outcomes of Acid Suppressive Therapy Use in Hematology/Oncology Patients at an Academic Medical Center

Prolonged versus short infusion rates for intravenous magnesium sulfate administration in hematopoietic cell transplant patients

Immune-mediated adverse events following influenza vaccine in cancer patients receiving immune checkpoint inhibitors

Evaluating Clostridioides difficile infection (CDI) treatment duration in hematology/oncology patients receiving concurrent non-CDI antibiotics

Evaluation of romiplostim for the treatment of secondary failure of platelet recovery among allogeneic hematopoietic stem cell transplant patients

Impact of fluoroquinolone prophylaxis on infectious-related outcomes after hematopoietic cell transplantation

Obinutuzumab: A Novel Anti-CD20 Monoclonal Antibody for Chronic Lymphocytic Leukemia

Bosutinib: a novel src/abl kinase inhibitor for chronic myelogenous leukemia

Fosaprepitant for the prevention of nausea and vomiting in patients receiving BEAM or high-dose melphalan before autologous hematopoietic stem cell transplant

The Hematopoietic Cell Transplant Pharmacist: Roles, Responsibilities, and Recommendations from the ASBMT Pharmacy Special Interest Group

Prognostic value of complete remission with superior platelet counts in acute myeloid leukemia

Outcomes for Patients with Multiple Myeloma after Receipt of Melphalan 200mg/m2 Versus 140 Mg/m2 for Autologous Stem Cell Transplantation

Academic Center Outreach to Community Practices Increases Transplant Referrals and Possibly Reduce Racial Disparities

Suchergebnisse filtern